Large-scale testing (Phase 3)Active Not RecruitingNCT03614234
What this trial is testing
Open Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease Patients
Who this might be right for
Fabry Disease
Chiesi Farmaceutici S.p.A. 29